clinicaltrialsarena1d
Bambusa Therapeutics doses first volunteers in Phase I bispecific AD trial
The Phase I trial will recruit approximately 98 healthy volunteers and adults living with atopic dermatitis at a single site ...
clinicaltrialsarena1d
NeOnc: bypassing the blood-brain barrier in brain cancer
NeOnc claims that its novel intranasal delivery platform will be able to bypass the blood-brain barrier and better target ...
clinicaltrialsarena1d
BullFrog AI partners with Eleison to enhance Phase III trial
The trial involves the pancreatic cancer therapy, glufosfamide. Credit: SewCreamStudio/Shutterstock. BullFrog AI Holdings has announced a partnership agreement with ...
clinicaltrialsarena1d
Immune-Onc doses first subject in trial of IO-108 for HCC
The trial is expected to enrol 40 subjects across 25 sites globally in the IO-108 part of the study. Credit: New Africa/Shutterstock. Immune-Onc Therapeutics has dosed the first subject in the Phase ...
clinicaltrialsarena1d
Why pharma is still far from a treatment for galactosemia
Current paediatric standard-of-care for galactosemia is a galactose-free diet. Image credit: Shutterstock / Photoongraphy. Nearly three months after an experimental treatment for classic galactosemia ...
clinicaltrialsarena2d
Imunon reports immunogenicity and safety data from DNA plasmid vaccine trial
The trial involved healthy volunteers who had been vaccinated previously against the Omicron XBB1.5 variant. Credit: BaLL LunLa / Shutterstock. Imunon has reported new immunogenicity and safety data ...
clinicaltrialsarena2d
Nektar completes enrolment in trial of rezpegaldesleukin for alopecia areata
The trial enrolled subjects who had not previously been treated with a janus kinase inhibitor or other biologic therapies. Credit: zorukis/Shutterstock. Nektar Therapeutics has concluded target ...
clinicaltrialsarena2d
AstraZeneca reports positive outcomes from breast cancer combo therapy trial
AstraZeneca’s camizestrant is presently under evaluation in Phase III trials targeting HR-positive breast cancer. Credit: © AstraZeneca 2025. AstraZeneca has ...
clinicaltrialsarena2d
Neuspera neuromodulation device hits “gold standard” in incontinence trial
The company also claims that its percutaneous approach allows it to avoid the potentially painful infections associated with the devices’ placement. Credit: Shutterstock / Super8. Neuspera Medical’s ...
clinicaltrialsarena3d
Trevi Therapeutics enrols all subjects in trial of Haduvio for chronic cough in IPF
Trevi Therapeutics has finished enrolling subjects in a trial of investigational Haduvio for treating chronic cough in IPF ...
clinicaltrialsarena3d
Elixirgen’s gene therapy shows promise in telomere biology disorders
Early results from the company’s single-arm trial saw the therapy able to partially repair the chemical responsible for ...
clinicaltrialsarena3d
Emalex eyes FDA approval for Tourette syndrome therapy after Phase III success
Among the 49 adult patients recruited for the trial, 41.2% of patients dosed with Ecopipam experienced some form of relapse. Credit: Shutterstock / Studio Romantic Emalex Biosciences is eyeing ...